Guselkumab

guselkumab · Janssen Biopharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

79 regulatory and trial events tracked for Guselkumab, covering 2017-07-17 to 2026-07-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis [Phase 3]